Member Info for BIGBONE

Testing the bottom resistance holding well , could be in for a nice rise today.

BWTFDIK . !

Don't think being held back as the new shares are hitting at the moment and the share price is holding up well . Bit of mopping up but don't think retail yet possibly smart investors getting in before news.

MADE validation must be very close now.

Someone must be expecting a blue sky scenario. News due shortly but nothing leaking yet .

Here is a detailed breakdown of the Namibia drilling outlook and the catalysts that could drive the share price upward.

​1. Namibia Drilling & Exploration Analysis

​Arkle’s Namibian portfolio consists of four Exclusive Prospecting Licenses (EPLs) covering 540 km^2. These are strategically located in "Alaskite Alley," adjacent to massive deposits like Rössing, Husab, and Trekkopje.

​Phase 1: Preparation (Ongoing - H1 2026)

​Before the drills start turning, the company is conducting high-resolution surveys to pinpoint targets.

​Geophysics: Horizontal Loop Electromagnetic (HLEM) surveys to find "paleochannels" (ancient riverbeds where uranium often settles).

​Airborne Surveys: Over 12,000 line-kilometers of radiometric and magnetic data to identify surface "hotspots."

​Historical Data: Re-logging and mapping old drill holes to validate previous findings, which showed surface grades as high as 3,855 ppm U_3O_8.

Loastapound sorry now filtered brings nothing to the message bd. Zero !

As of February 2026, the FCA has moved toward a model of Anonymised Aggregated Disclosures. This means instead of seeing "Hedge Fund X" is shorting Hemogenyx, you may see the total percentage of all shorts combined.

Nice to see shorts closing . can't be many more.!

I'm expecting a big jump in sp soon.

May ger your £1 sooner.

Think might see TR1 Friday fingers crossed director buying in .also.

Because Vlad knows its worth more than 2.5B.

GLA

Nice to see the shorts closing out on wards and upwards

GLA

U.S. Congress passed and President Trump signed a major $1.2 trillion government funding package (specifically the Fiscal Year 2026. Wonder how much if any will filter through to Hemogenyx?

Sorry ££££s

Think most of us know the share price minimum is at least worth 40p and around 70p or above before news !

Today’s move was backed by high volume, suggesting institutional or heavy retail interest, which often spills over into the next day's opening. £9.40 was tested several times before it broke which suggests the big money is slowly moving in.

Bwtfdik

Hope it can get past the £9.40 fibonacci resistance and away into double figures today .

Saint 68

Zero so far its all about the preparation.

While its primary listing is in London, it is traded on several international platforms to reach a wider investor base.

​As of early 2026, here is where you can find Hemogenyx trading:

​Primary Listing

​London Stock Exchange (LSE): This is the main listing under the ticker HEMO. It recently transitioned to the Main Market (Equity Shares Transition category) in late 2025, which typically offers higher visibility and liquidity than its previous sub-market status.

​Secondary & International Platforms

​To facilitate trading for non-UK investors, the stock is also available on several other platforms:

​United States (OTC Markets): Traded under the ticker HOPHF. This is common for UK-based biotechs that want exposure to US investors without the full regulatory burden of a Nasdaq or NYSE listing.

​Germany (Frankfurt & Stuttgart): You can find it listed under the ticker 5HU0. These listings allow European investors to trade the shares in Euros.

With the current share price activity could see another TR-1 shortly, before news.